IL17A and periodontitis: We revealed that miR-25-3p inhibitors suppress activation of γδ T cells in vitro and attenuate progression of periodontal inflammation and alveolar bone loss by reducing IL-17-producing T cells in a mouse model of ligature-induced periodontitis.